{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:44:56Z","timestamp":1768826696996,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016768","name":"National Lipid Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","award":["Pro00119196"],"award-info":[{"award-number":["Pro00119196"]}],"id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cjco.2024.08.005","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T20:22:46Z","timestamp":1723666966000},"page":"1395-1402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetic Testing for Familial Hypercholesterolemia: The Current State of Its Implementation in Canada"],"prefix":"10.1016","volume":"6","author":[{"given":"Adam I.","family":"Kramer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Christian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol","family":"Vaizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-3807","authenticated-orcid":false,"given":"Liam R.","family":"Brunham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2024.08.005_bib1","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jacc.2017.11.028","article-title":"Autosomal recessive hypercholesterolemia: long-term cardiovascular outcomes","volume":"71","author":"D'Erasmo","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib4","doi-asserted-by":"crossref","first-page":"100683","DOI":"10.1016\/j.ajpc.2024.100683","article-title":"Expanded genetic testing in familial hypercholesterolemia\u2014a single center's experience","volume":"18","author":"Brown","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib5","doi-asserted-by":"crossref","first-page":"e003816","DOI":"10.1161\/CIRCGEN.122.003816","article-title":"Familial hypercholesterolemia in the electronic medical records and genomics network: prevalence, penetrance, cardiovascular risk, and outcomes after return of results","volume":"16","author":"Dikilitas","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjco.2024.08.005_bib6","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2024.08.005_bib7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(21)01122-3","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2024.08.005_bib8","first-page":"1210","article-title":"Simplified Canadian Definition for Familial Hypercholesterolemia","volume":"34","author":"Ruel","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2024.08.005_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2024.08.005_bib11","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.9778\/cmajo.20220108","article-title":"Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study","volume":"11","author":"Guerin","year":"2023","journal-title":"CMAJ Open"},{"key":"10.1016\/j.cjco.2024.08.005_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2024.08.005_bib14","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/eurheartj\/ehx004","article-title":"Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia","volume":"38","author":"Tada","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2024.08.005_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archinte.163.1.65","article-title":"Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemia","volume":"163","author":"Umans-Eckenhausen","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjco.2024.08.005_bib17","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2016.01.008","article-title":"Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART Registry follow-up","volume":"67","author":"Perez de Isla","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib18","first-page":"1553","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia: update 2018","volume":"34","author":"Brunham","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib19","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib20","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2024.08.005_bib21","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2024.08.005_bib23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacl.2020.04.011","article-title":"Genetic testing in dyslipidemia: a scientific statement from the National Lipid Association","volume":"14","author":"Brown","year":"2020","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjco.2024.08.005_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2024.08.005_bib26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjco.2024.08.005_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.atherosclerosis.2018.05.040","article-title":"Familial hypercholesterolemia in Canada: initial results from the FH Canada national registry","volume":"277","author":"Brunham","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjco.2024.08.005_bib29","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacl.2016.07.011","article-title":"US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry","volume":"10","author":"Ahmad","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjco.2024.08.005_bib30","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/eurjpc\/zwac200","article-title":"Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations","volume":"29","author":"Gidding","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib31","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/eurheartj\/ehx136","article-title":"Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: Who does it in the world?","volume":"38","author":"Nordestgaard","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2024.08.005_bib32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacl.2022.07.014","article-title":"Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States","volume":"16","author":"Spencer","year":"2022","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.cjco.2024.08.005_bib34","author":"HealthLink"},{"key":"10.1016\/j.cjco.2024.08.005_bib35","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ijcard.2013.01.280","article-title":"A\u00a0systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia","volume":"167","author":"Ademi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2147\/CEOR.S264589","article-title":"Can standard health technology assessment approaches help guide the price of orphan drugs in Canada? a review of submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review","volume":"12","author":"Balijepalli","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.cjco.2024.08.005_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40273-023-01347-7","article-title":"Cost-effectiveness of screening strategies for familial hypercholesterolaemia: an updated systematic review","volume":"42","author":"Marquina","year":"2024","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cjco.2024.08.005_bib38","series-title":"Genetic Testing forFamilial Hypercholesterolemia: Recommendation","year":"2022"},{"key":"10.1016\/j.cjco.2024.08.005_bib39","article-title":"Genetic testing for familial hypercholesterolemia\u2014past, present, and future","volume":"62","author":"Futema","year":"2021","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.cjco.2024.08.005_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","article-title":"Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia","volume":"74","author":"Trinder","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2024.08.005_bib41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pathol.2018.10.014","article-title":"The role of genetic testing in dyslipidaemia","volume":"51","author":"Berberich","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.cjco.2024.08.005_bib42","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjco.2024.08.005_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCGENETICS.110.957365","article-title":"Psychological issues in genetic testing for inherited cardiovascular diseases","volume":"4","author":"Aatre","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjco.2024.08.005_bib47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cjco.2020.12.006","article-title":"Patient perspectives regarding genetic testing for familial hypercholesterolemia","volume":"3","author":"Marchand","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2024.08.005_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2020.11.027","article-title":"Genetic testing is essential for initiating statin therapy in children with familial hypercholesterolemia: examples from Scandinavia","volume":"316","author":"Svendsen","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjco.2024.08.005_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-0004.2004.00320.x","article-title":"Cascade genetic screening for familial hypercholesterolemia","volume":"66","author":"Leren","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.cjco.2024.08.005_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cjcpc.2023.05.006","article-title":"Exploring barriers and facilitators to indirect cascade screening for familial hypercholesteraemia in a paediatric\/parent population","volume":"2","author":"Dickson","year":"2023","journal-title":"CJC Pediatr Congenit Heart Dis"},{"key":"10.1016\/j.cjco.2024.08.005_bib51","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2024.08.005_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fgene.2020.00127","article-title":"The provision of genetic testing and related services in Quebec, Canada","volume":"11","author":"Unim","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.cjco.2024.08.005_bib53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s40142-014-0036-8","article-title":"The role of genetic counselors for patients with familial hypercholesterolemia","volume":"2","author":"Sturm","year":"2014","journal-title":"Curr Genet Med Rep"},{"key":"10.1016\/j.cjco.2024.08.005_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MOL.0000000000000732","article-title":"The genetic counselor's role in management of patients with dyslipidemia","volume":"32","author":"Brown","year":"2021","journal-title":"Curr Opin Lipidol"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X24003718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X24003718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:54:25Z","timestamp":1761843265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X24003718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2589790X24003718"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2024.08.005","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Testing for Familial Hypercholesterolemia: The Current State of Its Implementation in Canada","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2024.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}